Advertisement
Canada markets open in 5 hours 4 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7331
    +0.0007 (+0.10%)
     

  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     

  • Bitcoin CAD

    87,827.66
    +455.09 (+0.52%)
     

  • CMC Crypto 200

    1,389.83
    -6.71 (-0.48%)
     

  • GOLD FUTURES

    2,358.50
    +16.00 (+0.68%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,757.75
    +190.25 (+1.08%)
     

  • VOLATILITY

    15.53
    +0.16 (+1.04%)
     

  • FTSE

    8,119.26
    +40.40 (+0.50%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     

Company News For Dec 12, 2017

Zacks Equity Research
Updated
Northern Trust (NTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Shares of KMG Chemicals, Inc. KMG gained 0.3% after reporting first quarter 2018 earnings of $0.83 a share, surpassing the Zacks Consensus Estimate of $0.63

  • Shares of argenx SE ARGX rallied almost 79% after the company reported positive results from Phase 2 proof-of-concept trial of its drug ARGX-113 used in the treatment of generalized myasthenia gravis

  • Blueprint Medicines Corporation’s BPMC shares rallied 22.9% after the company reported positive new data from Phase 1 clinical trial of its drug Avapritinib

  • bluebird bio, Inc.’s BLUE shares surged 17.9% after reporting positive clinical results from Phase 1 multicenter study of LentiGlobin gene therapy used to cure sickle cell disease at the ASH2017


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
KMG Chemicals, Inc. (KMG) : Free Stock Analysis Report
 
bluebird bio, Inc. (BLUE) : Free Stock Analysis Report
 
Blueprint Medicines Corporation (BPMC) : Free Stock Analysis Report
 
ARGENX SE-ADR (ARGX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.